Basic Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Jul 21, 2016; 22(27): 6235-6245
Published online Jul 21, 2016. doi: 10.3748/wjg.v22.i27.6235
Figure 6
Figure 6 Inhibition of activating transcription factor 4 activity reintroduces drug sensitivity in activating transcription factor 4-overexpressing colorectal cancer cells. A: After transfection with shATF4 or vector, ATF4-overexpressing cells were exposed to the indicated doses of LOHP or 5-FU for 48 h. Cell viabilities were determined by the CCK-8 assay; B: The apoptotic rates were much higher in the shATF4-transfected cells than in the control cells. Annexin V/7-AAD staining assay was performed to detect apoptosis; C and D: Inhibition of ATF4 decreased the MDR1 expression. The mRNA and protein levels of MDR1 in the ATF4-depleted cells were examined by qRT-PCR and Western blot, respectively, and β-actin was used as an internal controls. aP < 0.05, bP < 0.01, vehicle vs shATF4. GD: Glucose deprivation; CRC: Colorectal cancer.